New England Biolabs Narrows Patent Infringement Lawsuit Against Enzymatics | GenomeWeb

NEW YORK (GenomeWeb News) –A lawsuit filed by New England Biolabs against Enzymatics has been "significantly narrowed," Enzymatics announced this week.

New England Biolabs has withdrawn its claims that Enzymatics infringed US Patent No. 5,670,637 and "conceded that US Patent No. 5,874,557 has expired, withdrawing its request for injunctive relief," Enzymatics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.